| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6489346 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US7399772 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US6699885 | RILEY CONSUMER | Substituted benzimidazole dosage forms and methods of using same |
Jul, 2016
(7 years ago) | |
| US6645988 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US5840737 | RILEY CONSUMER | Omeprazole solution and method for using same |
Jul, 2016
(7 years ago) | |
| US6780882 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
Zegerid Otc is owned by Riley Consumer.
Zegerid Otc contains Omeprazole; Sodium Bicarbonate.
Zegerid Otc has a total of 6 drug patents out of which 6 drug patents have expired.
Expired drug patents of Zegerid Otc are:
- US6489346
- US7399772
- US6699885
- US6645988
- US5840737
- US6780882
Zegerid Otc was authorised for market use on 01 December, 2009.
Zegerid Otc is available in capsule;oral, for suspension;oral dosage forms.
Zegerid Otc can be used as treating frequent heartburn.
The generics of Zegerid Otc are possible to be released after 15 July, 2016.
Drugs and Companies using OMEPRAZOLE; SODIUM BICARBONATE ingredient
Market Authorisation Date: 01 December, 2009
Treatment: Treating frequent heartburn
Dosage: CAPSULE;ORAL; FOR SUSPENSION;ORAL
ZEGERID OTC family patents
